The court was also informed that the central government will contribute funds towards the state corpus in the ratio of 60:40 and it would be used for only funding the entire treatment cost.
Justice Manmohan said that the court hoped and expected that the Cabinet of Delhi Government shall approve creation of a corpus fund for the rare diseases as "expeditiously as possible" as mentioned in minutes of meeting of January 29 under the chairmanship of Principal Secretary (Health).
Delhi government standing counsel Ramesh Singh also informed the court that it has been decided to constitute a Technical cum Administrative Committee for the state corpus which will be chaired by the secretary and have such technical experts as members as considered necessary and the panel will meet once in three months.
"The committee will identify and accredit institutions that will carry out diagnosis of rare diseases, and institutions that will provide treatment for rare diseases and the institutions that will both diagnose and treat rare diseases," he said.
The petitioners, through advocate Ashok Agarwal, have said they were denied treatment at the Employees' State Insurance Scheme of India (ESIC) hospitals here and did not have the capacity to bear the cost of the Enzyme Replacement Therapy (ERT).
During the day's hearing, the counsel said that two of the 122 patients require immediate medical attention as they were suffering from Spinal Muscular Atrophy (SMA) Type 1 disease and are residents of Delhi.
To this, the court asked their guardians to apply to Delhi government's Technical cum Administrative Committee for rare disease on February 5 and also asked the state to form a rare disease board within a week to consider these applications.
The high court had earlier asked the Centre to take urgent steps to make the National Policy for Treatment of Rare Diseases functional at the ground level.
The petitioners counsel had earlier said that patients have been running from pillar to post to get treatment.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
